Large granular lymphocytosis induced by dasatinib

Am J Hematol. 2021 Mar 1;96(3):395-396. doi: 10.1002/ajh.25953. Epub 2020 Sep 10.

Authors

Filipa Fernandes¹, Rita Ramalho¹, Rui Barreira¹, Margarida Silveira¹, Barbara J Bain²

Affiliations

¹ Hematology Laboratory, Department of Clinical Pathology, Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG), Lisbon, Portugal.
² St Mary's Hospital Campus of Imperial College London, St Mary's Hospital, London, UK.

PMID: 32757492
DOI: 10.1002/ajh.25953

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antineoplastic Agents / adverse effects*
Cell Nucleus / ultrastructure
Cytoplasmic Granules / ultrastructure
Dasatinib / adverse effects*
Drug Substitution
Female
Humans
Imatinib Mesylate / therapeutic use
Immunophenotyping
Killer Cells, Natural / pathology
Leukemia, Large Granular Lymphocytic / blood
Leukemia, Large Granular Lymphocytic / chemically induced*
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
Lymphocytes / pathology*

Substances

Antineoplastic Agents
Imatinib Mesylate
Dasatinib